Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26